G2 Cell Cycle Arrest and Cyclophilin A in Lentiviral Gene Transfer

Molecular Therapy

Volumn 14, Issue 4, 2006, Pages 546-554

  Zhang, Shangming ^a   Joseph, Guiandre ^a   Pollok, Karen ^a   Berthoux, Lionel ^b   Sastry, Lakshmi ^a   Luban, Jeremy ^b   Cornetta, Kenneth ^a  

^a INDIANA UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b Columbia University ^*  (United States)

Author keywords

cyclophilin A; cyclosporin A; gene therapy; genistein; human immunodeficiency virus 1; lentiviral vector; vesicular stomatitis virus glycoprotein

Indexed keywords

2 (2 AMINO 3 METHOXYPHENYL)CHROMONE; 2 MORPHOLINO 8 PHENYLCHROMONE; 4 (4 FLUOROPHENYL) 2 (4 METHYLSULFINYLPHENYL) 5 (4 PYRIDYL)IMIDAZOLE; CD34 ANTIGEN; CYCLOPHILIN A; DNA; GENISTEIN; LENTIVIRUS VECTOR; PROTEIN TYROSINE KINASE INHIBITOR; RETROVIRUS VECTOR; TYRPHOSTIN;

ANIMAL CELL; ARTICLE; CELL CYCLE ARREST; CELL CYCLE G2 PHASE; CELL DIVISION; CELL LINE; CONCENTRATION RESPONSE; CONTROLLED STUDY; ENZYME INHIBITION; GENE THERAPY; GENE TRANSFER; GENETIC TRANSDUCTION; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LEUKEMIA CELL LINE; LYMPHOCYTE; MOUSE; NONHUMAN; PERIPHERAL BLOOD STEM CELL; POLYMERASE CHAIN REACTION; QUANTITATIVE ANALYSIS; VIRAL GENE DELIVERY SYSTEM;

ANIMALS; CELLS, CULTURED; CYCLOPHILIN A; G2 PHASE; GENE DOSAGE; GENE EXPRESSION; GENE TRANSFER TECHNIQUES; GENETIC VECTORS; GENISTEIN; HUMANS; LENTIVIRUS; MICE; TIME FACTORS;

HUMAN IMMUNODEFICIENCY VIRUS 1; MURINAE; VESICULAR STOMATITIS VIRUS;

EID: 33748043344     PISSN: 15250016     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ymthe.2006.05.022     Document Type: Article

References (49)

1. Amado R.G., and Chen I.S. Lentiviral vectors-the promise of gene therapy within reach?. Science 285 (1999) 674-676
2. Blomer U., Naldini L., and Kafri T. Highly efficient and sustained gene transfer in adult neurons with a lentiviral vector. J. Virol. 71 (1997) 6641-6649
3. Naldini L., et al. In vivo gene delivery and stable transduction of nondividing cells by a lentiviral vector. Science 272 (1996) 263-267
4. Podsakoff G.M. Lentiviral vectors approach the clinic but fall back: National Institutes of Health Recombinant DNA Advisory Committee review of a first clinical protocol for use of a lentiviral vector. Mol. Ther. 4 (2001) 282-283
5. Lever A.M. Lentiviral vectors: progress and potential. Curr. Opin. Mol. Ther. 2 (2000) 488-496
6. Watson D.J., Kobinger G.P., Passini M.A., Wilson J.M., and Wolfe J.H. Targeted transduction patterns in the mouse brain by lentivirus vectors pseudotyped with VSV, Ebola, Mokola, LCMV, or MuLV envelope proteins. Mol. Ther. 5 (2002) 528-537
7. Handschumacher R.E., Harding M.W., Rice J., Drugge R.J., and Speicher D.W. Cyclophilin: a specific cytosolic binding protein for cyclosporin A. Science 226 (1984) 544-547
8. Gething M. Protein folding in the cells. Nature 355 (1992) 33-45
9. Franke E.K., Yuan H.E., and Luban J. Specific incorporation of cyclophilin A into HIV-1 virions. Nature 372 (1994) 359-362
10. Luban J. Absconding with the chaperone: essential cyclophilin-Gag interaction in HIV-1 virions. Cell 87 (1996) 1157-1159
11. Luban J., Bossolt K.L., Franke E.K., Kalpana G.V., and Goff S.P. Human immunodeficiency virus type 1 Gag protein binds to cyclophilins A and B. Cell 73 (1993) 1067-1078
12. Thali M., et al. Functional association of cyclophilin A with HIV-1 virions. Nature 372 (1994) 363-365
13. Braaten D., Franke E.K., and Luban J. Cyclophilin A is required for the replication of group M human immunodeficiency virus type 1 (HIV-1) and simian immunodeficiency virus SIV(CPZ)GAB but not group O HIV-1 or other primate immunodeficiency viruses. J. Virol. 70 (1996) 4220-4227
14. Saphire A.C., Bobardt M.D., and Gallay P.A. Human immunodeficiency virus type 1 hijacks host cyclophilin A for its attachment to target cells. Immunol. Res. 21 (2000) 211-217
15. Yin L., Braaten D., and Luban J. Human immunodeficiency virus type 1 replication is modulated by host cyclophilin A expression levels. J. Virol. 72 (1998) 6430-6436
16. Franke E.K., and Luban J. Inhibition of HIV-1 replication by cyclosporine A or related compounds correlates with the ability to disrupt the Gag-cyclophilin A interaction. Virology 222 (1996) 279-282
17. Braaten D., and Luban J. Cyclophilin A regulates HIV-1 infectivity, as demonstrated by gene targeting in human T cells. EMBO J. 20 (2001) 1300-1309
18. Saphire A.C., Bobardt M.D., and Gallay P.A. Cyclophilin A plays distinct roles in human immunodeficiency virus type 1 entry and postentry events, as revealed by spinoculation. J. Virol. 76 (2002) 4671-4677
19. Anonymous. Host cyclophilin A mediates HIV-1 attachment to target cells via heparans. EMBO J. 18 (1999) 6771-6785
20. Pushkarsky T., et al. CD147 facilitates HIV-1 infection by interacting with virus-associated cyclophilin A. Proc. Natl. Acad. Sci. USA 98 (2001) 6360-6365
21. Qing K., Wang X.S., Kube D.M., Ponnazhagan S., Bajpai A., and Srivastava A. Role of tyrosine phosphorylation of a cellular protein in adeno-associated virus 2-mediated transgene expression. Proc. Natl. Acad. Sci. USA 94 (1997) 10879-10884
22. Qing K., et al. Adeno-associated virus type 2-mediated gene transfer: correlation of tyrosine phosphorylation of the cellular single-stranded D sequence-binding protein with transgene expression in human cells in vitro and murine tissues in vivo. J. Virol. 72 (1998) 1593-1599
23. Qing K., Hansen J., Weigel-Kelley K.A., Tan M., Zhou S., and Srivastava A. Adeno-associated virus type 2-mediated gene transfer: role of cellular FKBP52 protein in transgene expression. J. Virol. 75 (2001) 8968-8976
24. Mah C., et al. Adeno-associated virus type 2-mediated gene transfer: role of epidermal growth factor receptor protein tyrosine kinase in transgene expression. J. Virol. 72 (1998) 9835-9843
25. Cohen P.S., et al. The critical role of p38 MAP kinase in T cell HIV-1 replication. Mol. Med. 3 (1997) 339-346
26. Kumar S., Orsini M.J., Lee J.C., McDonnell P.C., Debouck C., and Young P.R. Activation of the HIV-1 long terminal repeat by cytokines and environmental stress requires an active CSBP/p38 MAP kinase. J. Biol. Chem. 271 (1996) 30864-30869
27. Shapiro L., Heidenreich K.A., Meintzer M.K., and Dinarello C.A. Role of p38 mitogen-activated protein kinase in HIV type 1 production in vitro. Proc. Natl. Acad. Sci. USA 95 (1998) 7422-7426
28. Jacque J.M., et al. Modulation of HIV-1 infectivity by MAPK, a virion-associated kinase. EMBO J. 17 (1998) 2607-2618
29. Yang X., Chen Y., and Gabuzda D. ERK MAP kinase links cytokine signals to activation of latent HIV-1 infection by stimulating a cooperative interaction of AP-1 and NF-kappaB. J. Biol. Chem. 274 (1999) 27981-27988
30. Yang X., and Gabuzda D. Regulation of human immunodeficiency virus type 1 infectivity by the ERK mitogen-activated protein kinase signaling pathway. J. Virol. 73 (1999) 3460-3466
31. + T lymphocytes and macrophages. J. Virol. 77 (2003) 2539-2549
32. Alkhatib G., Locati M., Kennedy P.E., Murphy P.M., and Berger E.A. HIV-1 coreceptor activity of CCR5 and its inhibition by chemokines: independence from G protein signaling and importance of coreceptor downmodulation. Virology 234 (1997) 340-348
33. Lin Y.L., Mettling C., Portales P., Reynes J., Clot J., and Corbeau P. Cell surface CCR5 density determines the postentry efficiency of R5 HIV-1 infection. Proc. Natl. Acad. Sci. USA 99 (2002) 15590-15595
34. Gozlan J., Lathey J.L., and Spector S.A. Human immunodeficiency virus type 1 induction mediated by genistein is linked to cell cycle arrest in G2. J. Virol. 72 (1998) 8174-8180
35. Markowitz D., Goff S., and Bank A. Construction and use of a safe and efficient amphotropic packaging cell line. Virology 167 (1988) 400-406
36. Poon B., Jowett J.B., Stewart S.A., Armstrong R.W., Rishton G.M., and Chen I.S. Human immunodeficiency virus type 1 vpr gene induces phenotypic effects similar to those of the DNA alkylating agent, nitrogen mustard. J. Virol. 71 (1997) 3961-3971
37. Li Y., and Sarkar F.H. Gene expression profiles of genistein-treated PC3 prostate cancer cells. J. Nutr. 132 (2002) 3623-3631
38. Suzuki K., et al. Genistein, a soy isoflavone, induces glutathione peroxidase in the human prostate cancer cell lines LNCaP and PC-3. Int. J. Cancer 99 (2002) 846-852
39. Gummuluru S., and Emerman M. Cell cycle- and Vpr-mediated regulation of human immunodeficiency virus type 1 expression in primary and transformed T-cell lines. J. Virol. 73 (1999) 5422-5430
40. He J., Choe S., Walker R., Di Marzio P., Morgan D.O., and Landau N.R. Human immunodeficiency virus type 1 viral protein R (Vpr) arrests cells in the G2 phase of the cell cycle by inhibiting p34cdc2 activity. J. Virol. 69 (1995) 6705-6711
41. Zander K., et al. Cyclophilin A interacts with HIV-1 Vpr and is required for its functional expression. J. Biol. Chem. 278 (2003) 43202-43213
42. Zhou Y., and Ratner L. Phosphorylation of human immunodeficiency virus type 1 Vpr regulates cell cycle arrest. J. Virol. 74 (2000) 6520-6527
43. Goh W.C., et al. HIV-1 Vpr increases viral expression by manipulation of the cell cycle: a mechanism for selection of Vpr in vivo. Nat. Med. 4 (1998) 65-71
44. Brasey A., et al. The leader of human immunodeficiency virus type 1 genomic RNA harbors an internal ribosome entry segment that is active during the G2/M phase of the cell cycle. J. Virol. 77 (2003) 3939-3949
45. Kahl C.A., Marsh J., Fyffe J., Sanders D.A., and Cornetta K. Human immunodeficiency virus type 1-derived lentivirus vectors pseudotyped with envelope glycoproteins derived from Ross River virus and Semliki Forest virus. J. Virol. 78 (2004) 1421-1430
46. Dull T., et al. A third-generation lentivirus vector with a conditional packaging system. J. Virol. 72 (1998) 8463-8471
47. Pollok K.E., et al. Differential transduction efficiency of SCID-repopulating cells derived from umbilical cord blood and granulocyte colony-stimulating factor-mobilized peripheral blood. Hum. Gene Ther. 12 (2001) 2095-2108
48. Zhang S., and Kaplan M.H. The p38 mitogen-activated protein kinase is required for IL-12-induced IFN-gamma expression. J. Immunol. 165 (2000) 1374-1380
49. Butler S.L., Hansen M.S., and Bushman F.D. A quantitative assay for HIV DNA integration in vivo. Nat. Med. 7 (2001) 631-634